Hector Garcia, MD
Interventional Cardiology · The Villages, FLNPI 1114910031
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 68.2% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2019 at $9,510 and has fallen 85.8% since, to $1,347 in 2025.
Across 434 payments — averaging $73.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$22K
- Abbott$3K
- Boston Scientific$1K
- Impulse Dynamics (USA) Inc.$876
- Novartis$603
- Shockwave Medical, Inc$550
- plus $4K from 34 others
Across 63 payments — averaging $10,994 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$693K
What the payments were for
- Consulting fees$1,3004%
- Speaking & faculty fees$15,96350%
- Travel & lodging$5,28017%
- Food & beverage$8,86828%
- Other$2761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 165 | $21,606 |
| Abbott | 31 | $3,088 |
| Boston Scientific | 13 | $1,241 |
| Impulse Dynamics (USA) Inc. | 13 | $876 |
| Novartis | 39 | $603 |
| Shockwave Medical, Inc | 1 | $550 |
| Abiomed | 13 | $493 |
| Merck | 23 | $421 |
| Pfizer | 20 | $321 |
| Baxter Healthcare | 4 | $288 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $267 |
| Amgen | 13 | $217 |
| E.r. Squibb & Sons, L.L.C. | 12 | $196 |
| Johnson & Johnson | 10 | $178 |
| Kestra Medical Technology Services, Inc. | 8 | $169 |
| Edwards Lifesciences | 3 | $141 |
| Kowa Pharmaceuticals America, Inc. | 9 | $136 |
| AstraZeneca | 8 | $115 |
| Esperion Therapeutics, Inc. | 5 | $92 |
| Bayer | 3 | $65 |
| Philips North America LLC | 3 | $63 |
| Boehringer Ingelheim | 3 | $62 |
| Actelion Pharmaceuticals US, Inc. | 2 | $58 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Innovation Technologies Inc | 3 | $50 |
| Amarin Pharma, Inc. | 2 | $46 |
| Welch Allyn | 1 | $38 |
| Teleflex LLC | 2 | $33 |
| Lundbeck LLC | 1 | $23 |
| Cook Medical LLC | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Cordis US CORP. | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $19 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Biosense Webster, Inc. | 1 | $18 |
| GE HealthCare | 1 | $15 |
| Reflow Medical Inc | 1 | $13 |
| Livanova USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$15,428
- AVEIR$1,537
- Accent Pacemaker$750
- OPTIMIZER$560
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$550
- CareLink$544
- Impella$147
- Resolute$133
- LifeVest$131
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$107
How this compares
$31,688 in reported general payments places this provider in the 80th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 467 | $652,986 |
| XareltoRivaroxaban | 147 | $199,475 |
| Repatha SureclickEvolocumab | 177 | $158,503 |
| EntrestoSacubitril/Valsartan | 81 | $101,530 |
| JardianceEmpagliflozin | 35 | $50,358 |
| FarxigaDapagliflozin Propanediol | 38 | $43,795 |
| MultaqDronedarone Hcl | 22 | $38,815 |
| Praluent PenAlirocumab | 36 | $35,688 |
| VerquvoVericiguat | 26 | $27,089 |
| NexlizetBempedoic Acid/Ezetimibe | 28 | $21,271 |
| VascepaIcosapent Ethyl | 23 | $15,952 |
| Repatha SyringeEvolocumab | 12 | $12,682 |
| Ranolazine ErRanolazine | 141 | $12,225 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 21 | $8,907 |
| Ezetimibe | 378 | $8,832 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $321 | $652,986467 claims |
| Johnson & JohnsonXarelto | $178 | $199,475147 claims |
| NovartisEntresto | $603 | $101,53081 claims |
| Boehringer IngelheimJardiance | $62 | $50,35835 claims |
| AstraZenecaFarxiga | $115 | $43,79538 claims |
| Sanofi-aventis U.S. LLCMultaq | $51 | $38,81522 claims |
| MerckVerquvo | $421 | $27,08926 claims |
| Esperion Therapeutics, Inc.Nexlizet | $92 | $21,27128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in The Villages
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.